{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T01:27:05Z","timestamp":1789349225532,"version":"build-2803163510"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13075-016-1077-z","type":"journal-article","created":{"date-parts":[[2016,8,5]],"date-time":"2016-08-05T07:29:14Z","timestamp":1470382154000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Impact of disease activity and treatment of comorbidities on the risk of myocardial infarction in rheumatoid arthritis"],"prefix":"10.1186","volume":"18","author":[{"given":"Yvette","family":"Meissner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Zink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rn","family":"Kekow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Rockwitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anke","family":"Liebhaber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silke","family":"Zinke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Gerhold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Listing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Strangfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,5]]},"reference":[{"key":"1077_CR1","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","volume":"365","author":"IB McInnes","year":"2011","unstructured":"McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365:2205\u201319.","journal-title":"N Engl J Med."},{"key":"1077_CR2","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.acvd.2010.03.007","volume":"103","author":"C Meune","year":"2010","unstructured":"Meune C, Touze E, Trinquart L, Allanore Y. High risk of clinical cardiovascular events in rheumatoid arthritis: levels of associations of myocardial infarction and stroke through a systematic review and meta-analysis. Arch Cardiovasc Dis. 2010;103:253\u201361.","journal-title":"Arch Cardiovasc Dis."},{"key":"1077_CR3","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1136\/annrheumdis-2011-200726","volume":"71","author":"JA Avina-Zubieta","year":"2012","unstructured":"Avina-Zubieta JA, Thomas J, Sadatsafavi M, Lehman AJ, Lacaille D. Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis. 2012;71:1524\u20139.","journal-title":"Ann Rheum Dis."},{"key":"1077_CR4","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1002\/art.21397","volume":"52","author":"I Rincon del","year":"2005","unstructured":"del Rincon I, Freeman GL, Haas RW, O'Leary DH, Escalante A. Relative contribution of cardiovascular risk factors and rheumatoid arthritis clinical manifestations to atherosclerosis. Arthritis Rheum. 2005;52:3413\u201323.","journal-title":"Arthritis Rheum."},{"key":"1077_CR5","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1161\/01.CIR.0000099844.31524.05","volume":"108","author":"N Sattar","year":"2003","unstructured":"Sattar N, McCarey DW, Capell H, McInnes IB. Explaining how \"high-grade\" systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation. 2003;108:2957\u201363.","journal-title":"Circulation."},{"key":"1077_CR6","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1136\/ard.2006.059980","volume":"67","author":"A Gonzalez","year":"2008","unstructured":"Gonzalez A, Maradit Kremers H, Crowson CS, Ballman KV, Roger VL, Jacobsen SJ, O'Fallon WM, Gabriel SE. Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients? Ann Rheum Dis. 2008;67:64\u20139.","journal-title":"Ann Rheum Dis."},{"key":"1077_CR7","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0021-9150(99)00463-3","volume":"148","author":"JS Yudkin","year":"2000","unstructured":"Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis. 2000;148:209\u201314.","journal-title":"Atherosclerosis."},{"key":"1077_CR8","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/nrrheum.2015.40","volume":"11","author":"S Skeoch","year":"2015","unstructured":"Skeoch S, Bruce IN. Atherosclerosis in rheumatoid arthritis: is it all about inflammation? Nat Rev Rheumatol. 2015;11:390\u2013400.","journal-title":"Nat Rev Rheumatol."},{"key":"1077_CR9","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ejphar.2015.04.010","volume":"760","author":"PA Fordjour","year":"2015","unstructured":"Fordjour PA, Wang Y, Shi Y, Agyemang K, Akinyi M, Zhang Q, Fan G. Possible mechanisms of C-reactive protein mediated acute myocardial infarction. Eur J Pharmacol. 2015;760:72\u201380.","journal-title":"Eur J Pharmacol."},{"key":"1077_CR10","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/S0140-6736(12)60110-X","volume":"379","author":"I The","year":"2012","unstructured":"The I. The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis. Lancet. 2012;379:1214\u201324.","journal-title":"Lancet."},{"key":"1077_CR11","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1136\/annrheumdis-2013-204715","volume":"73","author":"J Zhang","year":"2014","unstructured":"Zhang J, Chen L, Delzell E, Muntner P, Hillegass WB, Safford MM, Millan IY, Crowson CS, Curtis JR. The association between inflammatory markers, serum lipids and the risk of cardiovascular events in patients with rheumatoid arthritis. Ann Rheum Dis. 2014;73:1301\u20138.","journal-title":"Ann Rheum Dis."},{"key":"1077_CR12","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.3899\/jrheum.130365","volume":"40","author":"S Ajeganova","year":"2013","unstructured":"Ajeganova S, Andersson ML, Frostegard J, Hafstrom I. Disease factors in early rheumatoid arthritis are associated with differential risks for cardiovascular events and mortality depending on age at onset: a 10-year observational cohort study. J Rheumatol. 2013;40:1958\u201366.","journal-title":"J Rheumatol."},{"key":"1077_CR13","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/art.22482","volume":"57","author":"MA Gonzalez-Gay","year":"2007","unstructured":"Gonzalez-Gay MA, Gonzalez-Juanatey C, Lopez-Diaz MJ, Pineiro A, Garcia-Porrua C, Miranda-Filloy JA, Ollier WE, Martin J, Llorca J. HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis. Arthritis Rheum. 2007;57:125\u201332.","journal-title":"Arthritis Rheum."},{"key":"1077_CR14","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/art.21204","volume":"52","author":"NJ Goodson","year":"2005","unstructured":"Goodson NJ, Symmons DP, Scott DG, Bunn D, Lunt M, Silman AJ. Baseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: a ten-year follow up study of a primary care-based inception cohort. Arthritis Rheum. 2005;52:2293\u20139.","journal-title":"Arthritis Rheum."},{"key":"1077_CR15","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1136\/annrheumdis-2013-204987","volume":"75","author":"I Navarro-Millan","year":"2016","unstructured":"Navarro-Millan I, Yang S, DuVall SL, Chen L, Baddley J, Cannon GW, Delzell ES, Zhang J, Safford MM, Patkar NM, Mikuls TR, Singh JA, Curtis JR. Association of hyperlipidaemia, inflammation and serological status and coronary heart disease among patients with rheumatoid arthritis: data from the National Veterans Health Administration. Ann Rheum Dis. 2016;75:341\u20137.","journal-title":"Ann Rheum Dis."},{"key":"1077_CR16","first-page":"2562","volume":"26","author":"S Wallberg-Jonsson","year":"1999","unstructured":"Wallberg-Jonsson S, Johansson H, Ohman ML, Rantapaa-Dahlqvist S. Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset. J Rheumatol. 1999;26:2562\u201371.","journal-title":"J Rheumatol"},{"key":"1077_CR17","doi-asserted-by":"crossref","first-page":"R131","DOI":"10.1186\/ar3442","volume":"13","author":"L Innala","year":"2011","unstructured":"Innala L, Moller B, Ljung L, Magnusson S, Smedby T, Sodergren A, Ohman ML, Rantapaa-Dahlqvist S, Wallberg-Jonsson S. Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study. Arthritis Res Ther. 2011;13:R131.","journal-title":"Arthritis Res Ther."},{"key":"1077_CR18","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/art.20878","volume":"52","author":"H Maradit-Kremers","year":"2005","unstructured":"Maradit-Kremers H, Nicola PJ, Crowson CS, Ballman KV, Gabriel SE. Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum. 2005;52:722\u201332.","journal-title":"Arthritis Rheum."},{"key":"1077_CR19","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1136\/annrheumdis-2013-204531","volume":"74","author":"EE Arts","year":"2015","unstructured":"Arts EE, Fransen J, den Broeder AA, Popa CD, van Riel PL. The effect of disease duration and disease activity on the risk of cardiovascular disease in rheumatoid arthritis patients. Ann Rheum Dis. 2015;74:998\u20131003.","journal-title":"Ann Rheum Dis."},{"key":"1077_CR20","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/ard.2009.113696","volume":"69","author":"MJ Peters","year":"2010","unstructured":"Peters MJ, Symmons DP, McCarey D, Dijkmans BA, Nicola P, Kvien TK, McInnes IB, Haentzschel H, Gonzalez-Gay MA, Provan S, Semb A, Sidiropoulos P, Kitas G, Smulders YM, Soubrier M, Szekanecz Z, Sattar N, Nurmohamed MT. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis. 2010;69:325\u201331.","journal-title":"Ann Rheum Dis."},{"key":"1077_CR21","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1002\/art.39267","volume":"67","author":"A Mantel","year":"2015","unstructured":"Mantel A, Holmqvist M, Nyberg F, Tornling G, Frisell T, Alfredsson L, Askling J. Risk factors for the rapid risk increase of acute coronary events in patients with new-onset rheumatoid arthritis: a nested case\u2013control study. Arthritis Rheumatol. 2015;67:2845\u201354.","journal-title":"Arthritis Rheumatol."},{"issue":"8","key":"1077_CR22","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1136\/ard.2008.089862","volume":"68","author":"BJ Radovits","year":"2009","unstructured":"Radovits BJ, Popa-Diaconu DA, Popa C, Eijsbouts A, Laan RF, van Riel PL, Fransen J. Disease activity as a risk factor for myocardial infarction in rheumatoid arthritis. Ann Rheum Dis. 2009;68(8):1271\u20136.","journal-title":"Ann Rheum Dis"},{"key":"1077_CR23","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1136\/ard.2004.031476","volume":"64","author":"A Zink","year":"2005","unstructured":"Zink A, Listing J, Kary S, Ramlau P, Stoyanova-Scholz M, Babinsky K, von Hinueber U, Gromnica-Ihle E, Wassenberg S, Antoni C, Herzer P, Kekow J, Schneider M, Rau R. Treatment continuation in patients receiving biological agents or conventional DMARD therapy. Ann Rheum Dis. 2005;64:1274\u20139.","journal-title":"Ann Rheum Dis."},{"key":"1077_CR24","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/jama.2009.146","volume":"301","author":"A Strangfeld","year":"2009","unstructured":"Strangfeld A, Listing J, Herzer P, Liebhaber A, Rockwitz K, Richter C, Zink A. Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents. JAMA. 2009;301:737\u201344.","journal-title":"JAMA."},{"key":"1077_CR25","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s003930050030","volume":"56","author":"J Lautenschlager","year":"1997","unstructured":"Lautenschlager J, Mau W, Kohlmann T, Raspe HH, Struve F, Bruckle W, Zeidler H. Comparative evaluation of a German version of the Health Assessment Questionnaire and the Hannover Functional Capacity Questionnaire. Z Rheumatol. 1997;56:144\u201355.","journal-title":"Z Rheumatol."},{"key":"1077_CR26","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1198\/106186006X137047","volume":"15","author":"BB Hansen","year":"2006","unstructured":"Hansen BB, Klopfer SO. Optimal full matching and related designs via network flows. J Comput Graph Stat. 2006;15:609\u201327.","journal-title":"J Comput Graph Stat."},{"key":"1077_CR27","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0140-6736(09)61717-7","volume":"375","author":"S Kaptoge","year":"2010","unstructured":"Emerging Risk Factors C, Kaptoge S, Di Angelantonio E, Lowe G, Pepys MB, Thompson SG, Collins R, Danesh J. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet. 2010;375:132\u201340.","journal-title":"Lancet"},{"key":"1077_CR28","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJMoa021993","volume":"347","author":"PM Ridker","year":"2002","unstructured":"Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002;347:1557\u201365.","journal-title":"N Engl J Med."},{"key":"1077_CR29","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1002\/art.22809","volume":"56","author":"WG Dixon","year":"2007","unstructured":"Dixon WG, Watson KD, Lunt M, Hyrich KL, British Society for Rheumatology Biologics Register Control Centre C, Silman AJ, Symmons DP, British Society for Rheumatology Biologics R. Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register. Arthritis Rheum. 2007;56:2905\u201312.","journal-title":"Arthritis Rheum"},{"key":"1077_CR30","doi-asserted-by":"publisher","unstructured":"Ljung L, Rantapaa-Dahlqvist S, Jacobsson LT, Askling J. Response to biological treatment and subsequent risk of coronary events in rheumatoid arthritis. Ann Rheum Dis. 2016;doi: 10.1136\/annrheumdis-2015-208995 . [Epub ahead of print].","DOI":"10.1136\/annrheumdis-2015-208995"},{"key":"1077_CR31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006242","volume":"4","author":"J Graf","year":"2009","unstructured":"Graf J, Scherzer R, Grunfeld C, Imboden J. Levels of C-reactive protein associated with high and very high cardiovascular risk are prevalent in patients with rheumatoid arthritis. PloS One. 2009;4, e6242.","journal-title":"PloS One."},{"key":"1077_CR32","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1136\/ard.2010.129916","volume":"70","author":"JD Greenberg","year":"2011","unstructured":"Greenberg JD, Kremer JM, Curtis JR, Hochberg MC, Reed G, Tsao P, Farkouh ME, Nasir A, Setoguchi S, Solomon DH, Investigators C. Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis. Ann Rheum Dis. 2011;70:576\u201382.","journal-title":"Ann Rheum Dis."},{"key":"1077_CR33","doi-asserted-by":"publisher","unstructured":"Zhang J, Xie F, Yun H, Chen L, Muntner P, Levitan EB, Safford MM, Kent ST, Osterman MT, Lewis JD, Saag K, Singh JA, Curtis JR. Comparative effects of biologics on cardiovascular risk among older patients with rheumatoid arthritis. Ann Rheum Dis. 2016;doi: 10.1136\/annrheumdis-2015-207870 . [Epub ahead of print].","DOI":"10.1136\/annrheumdis-2015-207870"},{"key":"1077_CR34","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/rheumatology\/kes353","volume":"52","author":"JA Avina-Zubieta","year":"2013","unstructured":"Avina-Zubieta JA, Abrahamowicz M, De Vera MA, Choi HK, Sayre EC, Rahman MM, Sylvestre MP, Wynant W, Esdaile JM, Lacaille D. Immediate and past cumulative effects of oral glucocorticoids on the risk of acute myocardial infarction in rheumatoid arthritis: a population-based study. Rheumatology. 2013;52:68\u201375.","journal-title":"Rheumatology."},{"key":"1077_CR35","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/art.22418","volume":"56","author":"JM Davis III","year":"2007","unstructured":"Davis III JM, Maradit Kremers H, Crowson CS, Nicola PJ, Ballman KV, Therneau TM, Roger VL, Gabriel SE. Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum. 2007;56:820\u201330.","journal-title":"Arthritis Rheum."},{"key":"1077_CR36","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/art.38210","volume":"66","author":"I Rincon del","year":"2014","unstructured":"del Rincon I, Battafarano DF, Restrepo JF, Erikson JM, Escalante A. Glucocorticoid dose thresholds associated with all-cause and cardiovascular mortality in rheumatoid arthritis. Arthritis Rheumatol. 2014;66:264\u201372.","journal-title":"Arthritis Rheumatol."},{"key":"1077_CR37","doi-asserted-by":"publisher","unstructured":"Baillet A, Gossec L, Carmona L, Wit M, van Eijk-Hustings Y, Bertheussen H, Alison K, Toft M, Kouloumas M, Ferreira RJ, Oliver S, Rubbert-Roth A, van AS, Dixon WG, Finckh A, Zink A, Kremer J, Kvien TK, Nurmohamed M, van der Heijde D, Dougados M. Points to consider for reporting, screening for and preventing selected comorbidities in chronic inflammatory rheumatic diseases in daily practice: a EULAR initiative. Ann Rheum Dis. 2016;doi: 10.1136\/annrheumdis-2016-209233 . [Epub ahead of print].","DOI":"10.1136\/annrheumdis-2016-209233"},{"key":"1077_CR38","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/acr.21935","volume":"65","author":"L Gossec","year":"2013","unstructured":"Gossec L, Salejan F, Nataf H, Nguyen M, Gaud-Listrat V, Hudry C, Breuillard P, Dernis E, Boumier P, Durandin-Truffinet M, Fannius J, Fechtenbaum J, Izou-Fouillot MA, Labatide-Alanore S, Lebrun A, LeDevic P, LeGoux P, Sacchi A, Salliot C, Sparsa L, d'Andre FL, Dougados M, Network RR. Challenges of cardiovascular risk assessment in the routine rheumatology outpatient setting: an observational study of 110 rheumatoid arthritis patients. Arthritis Care Res. 2013;65:712\u20137.","journal-title":"Arthritis Care Res."},{"key":"1077_CR39","doi-asserted-by":"crossref","first-page":"R270","DOI":"10.1186\/ar4118","volume":"14","author":"SS Desai","year":"2012","unstructured":"Desai SS, Myles JD, Kaplan MJ. Suboptimal cardiovascular risk factor identification and management in patients with rheumatoid arthritis: a cohort analysis. Arthritis Res Ther. 2012;14:R270.","journal-title":"Arthritis Res Ther."},{"key":"1077_CR40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0130709","volume":"10","author":"SA Provan","year":"2015","unstructured":"Provan SA, Berg IJ, Hammer HB, Mathiessen A, Kvien TK, Semb AG. The impact of newer biological disease modifying anti-rheumatic drugs on cardiovascular risk factors: a 12-month longitudinal study in rheumatoid arthritis patients treated with rituximab, Abatacept and Tociliziumab. PloS One. 2015;10, e0130709.","journal-title":"PloS One."},{"key":"1077_CR41","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/art.38920","volume":"67","author":"VU Rao","year":"2015","unstructured":"Rao VU, Pavlov A, Klearman M, Musselman D, Giles JT, Bathon JM, Sattar N, Lee JS. An evaluation of risk factors for major adverse cardiovascular events during tocilizumab therapy. Arthritis Rheumatol. 2015;67:372\u201380.","journal-title":"Arthritis Rheumatol."}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-016-1077-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T16:02:36Z","timestamp":1498320156000},"score":1,"resource":{"primary":{"URL":"http:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-016-1077-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,5]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1077"],"URL":"https:\/\/doi.org\/10.1186\/s13075-016-1077-z","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,5]]},"article-number":"183"}}